Table 2 Microbiology cultures and antibiotic therapy of surgical site infection
Isolated microorganisms | |
|---|---|
Escherichia coli | 20.4 % (n = 55) |
Pseudomonas aeruginosa | 19.3 % (n = 52) |
Candida albicans | 13.7 % (n = 37) |
Staphylococcus coagulase negative | 12 % (n = 32) |
Staphylococcus epidermidis | 7.4 % (n = 20) |
Enterococcus faecalis | 4.4 % (n = 12) |
Candida spp. (Other than C. albicans) | 3.3 % (n = 9) |
Acinetobacter baumanii | 2.9 % (n = 8) |
Klebsiella spp. | 2.6 % (n = 7) |
Proteus mirabilis | |
Methicillin resistant Staphylococcus aureus | 2.2 % (n = 6) |
Staphylococcus aureus | 1.8 % (n = 5) |
Enterococcus faecium | |
Enterobacter cloacae | 1.6 % (n = 4) |
Clostridium spp. | |
Enterobacter aerogenes | 1.1 % (n = 3) |
Other | |
Antibiotic therapy | |
Meropenem | 28.6 % (n = 203) |
Piperacillin-tazobactam | 26.1 % (n = 185) |
Teicoplanin | 12.4 % (n = 89) |
Cloxacillin | 7.7 % (n = 55) |
Fluconazole | 7.7 % (n = 54) |
Ertapenem | 6.7 % (n = 48) |
Imipenem-cilastatin | 4.8 % (n = 34) |
Other | 6 % (n = 42) |